Polysorbate 20 degradation in biotherapeutic formulations and its

Enzyme-induced hydrolysis of polysorbate 20 and formation of subvisible particles was evaluated using relevant analytical techniques to understand the impact of

PDF) Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases

Formulation mitigations for particle formation induced by enzymatic hydrolysis of polysorbate 20 in protein-based drug products: insights from a full-factorial longitudinal study, AAPS Open

Quantitative Analysis of Polysorbate 20/80 in Protein-Based Biopharmaceuticals Using A One-Pot RPLC-MS Based Platform Method

Polysorbate, the Good, the Bad and the Ugly American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology

Degradation of polysorbates 20 and 80 catalysed by histidine chloride buffer - ScienceDirect

Profiling Active Enzymes for Polysorbate Degradation in Biotherapeutics by Activity-Based Protein Profiling

Polysorbates versus Hydroxypropyl Beta-Cyclodextrin: Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies

Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes - ScienceDirect

Polysorbates versus Hydroxypropyl Beta-Cyclodextrin: Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies

View of ANALYSIS OF POLYSORBATE 80 SOLUTION STABILITY UNDER STRESS CONDITIONS TO ENSURE ITS QUALITY AS A BIOPHARMACEUTICAL EXCIPIENT

Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: Structure and degradation pathways - Kerwin - 2008 - Journal of Pharmaceutical Sciences - Wiley Online Library